- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Lung Cancer, Non-small Cell in United Kingdom
Total 10110 results
-
Ohio State University Comprehensive Cancer CenterNational Institute on Aging (NIA)RecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Extensive Stage Lung Small Cell Carcinoma | Unresectable Lung Non-Small Cell Carcinoma | Advanced Lung Non-Small Cell Carcinoma | Advanced... and other conditionsUnited States
-
Synta Pharmaceuticals Corp.CompletedStage IIIB Non-Small Cell Lung Cancer | Stage IV Non-Small Cell Lung CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Unresectable Malignant Neoplasm | Metastatic Neoplasm | Recurrent NeoplasmUnited States
-
Georgetown UniversityGenentech, Inc.RecruitingNon-squamous Non-small-cell Lung CancerUnited States
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerUnited States, France, Netherlands
-
Jeffrey ClarkeMerck Sharp & Dohme LLC; Grid TherapeuticsSuspendedNon Small Cell Lung Cancer | Metastatic NSCLC | Recurrent Non Small Cell Lung CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedMetastatic Non Small Cell Lung Cancer | Recurrent Non Small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | Minimal Residual Disease | NSCLC Stage IV | Nsclc | Metastatic Non Small Cell Lung CancerUnited States
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small CellGermany, United Kingdom
-
PfizerCompletedNon-small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Brazil, Spain, United Kingdom, Singapore, Canada, Hong Kong, Poland, Puerto Rico
-
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator...Not yet recruitingNon-small Cell Lung CancerUnited States
-
Columbia UniversityNot yet recruitingNon Small Cell Lung CancerUnited States
-
Sanguine BiosciencesRecruitingNon Small Cell Lung CancerUnited States
-
Columbia UniversityRecruitingNon Small Cell Lung CancerUnited States
-
CelgeneTerminatedNon Small Cell Lung CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteMerck Sharp & Dohme LLCActive, not recruitingLung Cancer | Non-small Cell Lung CancerUnited States
-
Zhonglin HaoBayerActive, not recruiting
-
University of PennsylvaniaTerminatedNon Small Cell Lung CancerUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbSuspendedNon-small Cell Lung CancerUnited States
-
Liza Villaruz, MDCompleted
-
Nilogen OncosystemsHenry Ford Health SystemUnknownNon Small Cell Lung CancerUnited States
-
Milton S. Hershey Medical CenterSanofiTerminatedNon Small Cell Lung CancerUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Cellectar Biosciences, Inc.Completed
-
University of VirginiaCompletedNon Small Cell Lung CancerUnited States
-
Massachusetts General HospitalGenentech, Inc.TerminatedNon-small Cell Lung CancerUnited States
-
Virginia Commonwealth UniversityTerminatedNon-small Cell Lung CancerUnited States
-
SCRI Development Innovations, LLCGenentech, Inc.CompletedNon Small Cell Lung CancerUnited States
-
University of ChicagoBristol-Myers SquibbTerminatedNon-small Cell Lung CancerUnited States
-
BIND TherapeuticsCompletedSquamous Cell Non-small Cell Lung Cancer | KRAS Positive Patients With Non-small Cell Lung CancerUnited States, Russian Federation
-
NovaRx CorporationCompletedLung Neoplasm | Carcinoma Non-small Cell Lung Cancer Stage IIIA | Carcinoma Non-small Cell Lung Cancer Stage IIIB | Carcinoma Non-small Cell Lung Cancer Stage IVUnited States, Hungary, United Kingdom, Netherlands, Canada, India, Poland, Serbia
-
AstraZenecaApproved for marketingNon Small Cell Lung Cancer | Cancer of the Head and NeckPoland, Germany, Hungary, United Kingdom
-
Cancer Research UKBarinthus BiotherapeuticsSuspendedEsophageal Neoplasms | Non-small Cell Lung Cancer (NSCLC)United Kingdom
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingStage IIIA Lung Non-Small Cell Cancer AJCC v7 | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC v7United States, Canada
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Malignant Pleural EffusionUnited States
-
Roswell Park Cancer InstituteActive, not recruitingNon Small Cell Lung CancerUnited States
-
University of California, San FranciscoNational Comprehensive Cancer NetworkCompletedNon-small Cell Lung CancerUnited States
-
University of FloridaDiaCarta, Inc.Terminated
-
West Virginia UniversityAmerican Cancer Society, Inc.TerminatedNon Small Cell Lung CancerUnited States
-
West Virginia UniversityTerminatedNon-small Cell Lung CancerUnited States
-
Leo W. Jenkins Cancer CenterTerminatedNon Small Cell Lung CancerUnited States
-
SanofiTerminated
-
University of Texas Southwestern Medical CenterRecruitingNon Small Cell Lung CancerUnited States
-
University of LouisvilleJames Graham Brown Cancer CenterRecruiting
-
Case Comprehensive Cancer CenterActive, not recruitingNon Small Cell Lung CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedNon Small Cell Lung CancerUnited States
-
University of Texas Southwestern Medical CenterUnited States Department of DefenseCompleted
-
Stephanie SmiddyWithdrawnNon Small Cell Lung CancerUnited States
-
University of FloridaConcordia Laboratories Inc.TerminatedNon Small Cell Lung CancerUnited States
-
University of Wisconsin, MadisonPfizer; Genentech, Inc.Completed
-
H. Lee Moffitt Cancer Center and Research InstituteCompleted